188 related articles for article (PubMed ID: 31089161)
1. Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients.
Villanueva-Romero R; Gutiérrez-Cañas I; Carrión M; González-Álvaro I; Rodríguez-Frade JM; Mellado M; Martínez C; Gomariz RP; Juarranz Y
Sci Rep; 2019 May; 9(1):7383. PubMed ID: 31089161
[TBL] [Abstract][Full Text] [Related]
2. Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.
Lara-Marquez M; O'Dorisio M; O'Dorisio T; Shah M; Karacay B
J Immunol; 2001 Feb; 166(4):2522-30. PubMed ID: 11160313
[TBL] [Abstract][Full Text] [Related]
3. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.
Sun W; Hong J; Zang YC; Liu X; Zhang JZ
Int Immunol; 2006 Dec; 18(12):1691-700. PubMed ID: 17077178
[TBL] [Abstract][Full Text] [Related]
5. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
Cunha-Reis D; Ribeiro JA; Sebastião AM
Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.
Seoane IV; Ortiz AM; Piris L; Lamana A; Juarranz Y; García-Vicuña R; González-Álvaro I; Gomariz RP; Martínez C
PLoS One; 2016; 11(2):e0149141. PubMed ID: 26881970
[TBL] [Abstract][Full Text] [Related]
7. Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.
Vomhof-DeKrey EE; Sandy AR; Failing JJ; Hermann RJ; Hoselton SA; Schuh JM; Weldon AJ; Payne KJ; Dorsam GP
Peptides; 2011 Oct; 32(10):2058-66. PubMed ID: 21878358
[TBL] [Abstract][Full Text] [Related]
8. VPAC
Cunha-Reis D; Ribeiro JA; de Almeida RFM; Sebastião AM
Br J Pharmacol; 2017 Dec; 174(24):4725-4737. PubMed ID: 28945273
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the relative abundance of the vasoactive intestinal peptide receptors (VPAC1 and VPAC2) and functions in uterine contractility during inflammation.
Palus K; Całka J; Jana B
Anim Reprod Sci; 2021 Feb; 225():106680. PubMed ID: 33388613
[TBL] [Abstract][Full Text] [Related]
10. Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer.
Valdehita A; Bajo AM; Fernández-Martínez AB; Arenas MI; Vacas E; Valenzuela P; Ruíz-Villaespesa A; Prieto JC; Carmena MJ
Peptides; 2010 Nov; 31(11):2035-45. PubMed ID: 20691743
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitro.
Yang J; Shi QD; Song TB; Feng GF; Zang WJ; Zong CH; Chang L
Peptides; 2013 Apr; 42():105-11. PubMed ID: 23340020
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP
Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383
[TBL] [Abstract][Full Text] [Related]
13. Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence.
Villanueva-Romero R; Lamana A; Flores-Santamaría M; Carrión M; Pérez-García S; Triguero-Martínez A; Tomero E; Criado G; Pablos JL; González-Álvaro I; Martínez C; Juarranz Y; Gomariz RP; Gutiérrez-Cañas I
Cells; 2020 Dec; 9(12):. PubMed ID: 33291545
[TBL] [Abstract][Full Text] [Related]
14. Effect of VIP on intracellular [Ca2+], extracellular regulated kinase 1/2, and secretion in cultured rat conjunctival goblet cells.
Li D; Jiao J; Shatos MA; Hodges RR; Dartt DA
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2872-84. PubMed ID: 23518767
[TBL] [Abstract][Full Text] [Related]
15. VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model.
Storka A; Burian B; Führlinger G; Clive B; Sun T; Crevenna R; Gsur A; Mosgöller W; Wolzt M
J Transl Med; 2013 May; 11():117. PubMed ID: 23651810
[TBL] [Abstract][Full Text] [Related]
16. Atypical nuclear localization of VIP receptors in glioma cell lines and patients.
Barbarin A; Séité P; Godet J; Bensalma S; Muller JM; Chadéneau C
Biochem Biophys Res Commun; 2014 Nov; 454(4):524-30. PubMed ID: 25450687
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
[TBL] [Abstract][Full Text] [Related]
18. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide maintains the nonpathogenic profile of human th17-polarized cells.
Jimeno R; Leceta J; Martínez C; Gutiérrez-Cañas I; Carrión M; Pérez-García S; Garín M; Mellado M; Gomariz RP; Juarranz Y
J Mol Neurosci; 2014 Nov; 54(3):512-25. PubMed ID: 24805298
[TBL] [Abstract][Full Text] [Related]
20. Human CD4
Villanueva-Romero R; Cabrera-Martín A; Álvarez-Corrales E; Carrión M; Pérez-García S; Lamana A; Castro-Vázquez D; Martínez C; Gomariz RP; Gutiérrez-Cañas I; Juarranz Y
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
